Leahi Fund For Pulmonary Research - Scientific Research Grants

Hawai'i Community Foundation

Suggest an update

Anticipated deadline: Mar 3, 2021 6:00pm PST (Letter of inquiry)

Grant amount: Up to US $40,000

Fields of work: Respiratory Diseases & Systems

Applicant type: Individuals, Nonprofit

Funding uses: Research

Location of project: Hawaii

Location of residency: Hawaii

View website    Save

About this funder:



The purpose of the Leahi Fund is “to support programs of research and education in, and the prevention of, pulmonary disease."

A new funding opportunity is available to support a planning grant for qualified and experienced Clinical Research Investigators who are interested in conducting research related to the prevention and treatment of pulmonary conditions that are relevant to Hawaii and its local communities. The overarching goal of this research opportunity is to achieve health equity by improving the care of rural and/or underserved communities disproportionately impacted by respiratory conditons in their environment. 

This is a 2 phase grant application process.

  • Phase I - Planning Grant: This first solicitation calls for an abbreviated summary application due March 3, 2020, for a 6-month planning grant to support the development of a full proposal application. The Leahi Fund may award up to $40,000 to one or two promising projects for a 6-month period starting April 2020. The Leahi Fund Advisory Committee may request additional information from applicants.
  • Phase II - Research Grant: The specifics of the full proposal - Phase II - will be included in the forthcoming notice of the planning grant award. Given the extend of the funding, only one project may be awarded up to $525,000 over a 3-year period. 

You can learn more about this opportunity by visiting the funder's website.


  • Applicants must be in Hawai‘i.
  • Applicants must be affiliated with tax-exempt organizations classified by the Internal Revenue Service as 501(c)(3), or with units of government.
  • There must be a principal investigator (PI) and a co-investigator (Co-I) comprising the leadership team.
  • One of the investigators should be an academic clinical researcher from a university and the other should be a community researcher, with either partner acting as PI or Co-I.
  • A community partner institution must be identified such as a community hospital or health center, other healthcare organization, and/or non-healthcare community organization. The community researcher must represent the community partner institution that is identified.